Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 37.490
- +0.440+1.19%
Close Jan 8 16:00 ET
- 37.890
- +0.400+1.07%
Pre 04:12 ET
2.46BMarket Cap-19.32P/E (TTM)
37.800High35.030Low936.19KVolume36.750Open37.050Pre Close34.62MTurnover1.44%Turnover RatioLossP/E (Static)65.68MShares53.69052wk High10.36P/B2.44BFloat Cap21.85052wk Low--Dividend TTM65.12MShs Float302.500Historical High--Div YieldTTM7.48%Amplitude2.140Historical Low36.980Avg Price1Lot Size
Tandem Diabetes Care News
Bernstein Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $44
Tandem Diabetes Care (NASDAQ:TNDM) Shareholders Have Endured a 71% Loss From Investing in the Stock Three Years Ago
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tandem Diabetes Care Has Signed A Multi-Year Collaboration Agreement With The University Of Virginia Center For Diabetes Technology To Advance Research And Development Efforts On Fully Automated Closed-Loop Insulin Delivery Systems
Express News | Tandem Diabetes Care Enters Multi-Year Research Collaboration With Uva Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
Bernstein Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $42
Express News | Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
Express News | Tandem Diabetes Care Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
RBC Capital Remains a Buy on Tandem Diabetes Care (TNDM)
The Market Lifts Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares 25% But It Can Do More
Citi Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $50
Express News | Tandem T:Slim X2 Insulin Pump Now Compatible With Dexcom G7 Cgm in Canada
Tandem T:slim X2 Insulin Pump Now Compatible With Dexcom G7 CGM in Canada
Express News | Tandem Diabetes Care Inc : Canaccord Genuity Raises Target Price to $63 From $56
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $40
Tandem Diabetes Care Poised for Growth: Expansion Into Type 2 Diabetes and Strategic Integration Drive Buy Rating
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?
United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly - ResearchAndMarkets.com
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.